Autolus Therapeutics Ltd (AUTL) reported its third-quarter 2025 earnings, revealing a net loss per share (EPS) of -$0.30, wider than the forecasted -$0.2171, resulting in a negative surprise of 38.19% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback